Braskem S.A. (NYSE: BAK) is a major Brazilian petrochemical company. It produces thermoplastic resins and other chemical products used in various industries. The company operates in a competitive global market, facing other large chemical producers. Braskem recently filed its Annual Report on Form 20-F for the year ending December 31, 2025, detailing its financial performance in the petrochemicals industry.
On April 21, 2026, analyst Vicente Neto of Bradesco downgraded Braskem to an Underperform rating from Neutral. A new price target of $1.50 was set for the stock. At the time of the report, the stock's price was $3.64, which means the new target represents a potential downside of approximately 58.79%. This analyst downgrade highlights growing concerns about the company's investment outlook.
This negative outlook follows several challenging developments. The Pomerantz Law Firm is investigating Braskem for potential securities fraud or other unlawful business practices, as highlighted by GlobeNewswire. This investigation began after a September 2025 announcement from Braskem that caused its American Depositary Receipt (ADR) price to fall by 14.71%, impacting investor confidence.
Braskem's financial performance also reflects these difficulties. In March 2026, Braskem reported widening losses for its fourth quarter and full-year 2025 financial results. This indicates growing financial pressure on the company, which likely contributed to the analyst's downgrade.
Amid these issues, Braskem is undergoing a major ownership change. As highlighted by Reuters, controlling shareholders Novonor and NSP Investimentos have signed an agreement to sell their stake in Braskem to private equity fund Shine I. This introduces a significant shift in the company's corporate structure and Brazilian market presence.
